December 14, 2022 Experience Skymark Airlines ¥37.4 billion IPO The shares are listed on the Tokyo Stock Exchange
November 22, 2022 Experience TMS ¥2.9 billion global IPO The shares are listed on the Tokyo Stock Exchange
November 14, 2022 Experience Atour Lifestyle Holdings $52 million IPO We advised Atour on its IPO and Nasdaq listing
October 25, 2022 Experience Prime Medicine $175 million IPO The shares are listed on the Nasdaq Global Market
September 22, 2022 Experience InnoCare Pharma RMB2.9 billion Shanghai IPO This is the largest A-share listing by an overseas-listed biotechnology company in 2022 so far
September 21, 2022 Experience Nayax direct listing The shares are listed on the Nasdaq Global Select Market
September 19, 2022 Experience Interra Acquisition HK$1 billion IPO We advised the SPAC on its IPO and HKEX listing
September 1, 2022 Experience Biocytogen HK$549 million IPO We advised Biocytogen on its IPO and HKEX listing
July 12, 2022 Experience Tuya global offering and dual primary listing on the Hong Kong Stock Exchange We advised Tuya Inc. on its HK$141 million global offering and dual primary listing on the HKEX